Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Renal Cell Carcinoma
Management of Renal Cell Carcinoma (RCC)
For patients with early stage RCC, several factors are taken into consideration to help determine which surgical approach should be adopted. Careful selection of patients for appropriate surgery, depending upon the extent of disease is very critical. Also, with the approval of adjuvant sunitinib, the treatment paradigm for early stage disease is changing. It is important for clinicians’ to understand the patients who would benefit from adjuvant systemic therapy.
Patients with advanced RCC will be exposed to multiple agents during their continuum of care. Clinicians need to stay current with their knowledge of the benefits and risks of the multiple acceptable treatment strategies and apply high-level clinical evidence and expert advice to individualize treatment and maximize outcomes for these patients.
This educational program is designed to meet the educational needs of physicians, nurses, pharmacists, and other healthcare professionals who manage patients with cancer.
Following this activity, participants should be able to:
- Identify key patient and clinical factors that influence choice of adjuvant therapy for early stage renal cell carcinoma (RCC).
- Evaluate the benefits and risks associated with therapies and use evidence-based data and patient characteristics to select optimal first line treatment for patients with advanced RCC.
- Design optimal treatment plans after disease progression in patients with advanced RCC.
Elizabeth R. Plimack, MD, MS
Fox Chase Cancer Center
Robert G. Uzzo, MD
Fox Chase Cancer Center
Disclosure of Relevant Financial Relationships
All faculty and activity planners participating in NCCN continuing education activities are expected to disclose any relevant financial relationships with a commercial interest as defined by the ACCME’s, ANCC’s, and ACPE’s Standards for Commercial Support. All faculty presentations have been reviewed for adherence to the ACCME’s Criterion 7: The provider develops activities/educational interventions independent of commercial interests (SCS 1, 2, and 6) by experts on the topics. Full disclosure of faculty relationships will be made prior to the activity.
National Comprehensive Cancer Network (NCCN) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
NCCN designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 1.0 hour of Category 1 credit for completing this activity.
National Comprehensive Cancer Network (NCCN) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
NCCN designates this educational activity for a maximum of 1.0 contact hour.
This program has been pre-approved by The Commission for Case Manager Certification to provide continuing education credit to CCM® board certified case managers. The course is approved for 1.0 CE contact hour. Activity Code: I00034811; Approval #: 180004496
|National Comprehensive Cancer Network (NCCN) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.|
NCCN designates this knowledge-based continuing education activity for 1.0 contact hour (0.1 CEUs) of continuing education credit. UAN: 0836-0000-18-143-L01-P
- 1.00 ACPE contact hours
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC contact hours
- 1.00 CCM clock hours
- 1.00 Participation
Click the Take Course button to register for this upcoming live webinar.
This webinar will be presented live one time only on Friday, December 21, 2018, from 1:30 - 2:30 PM Eastern Standard Time (EST) (UTC -5). To convert the start time of this webinar for other time zones, click here.
To complete this activity, users will need:
- A device with an Internet connection and sound playback capability
- One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari
- Internet Explorer is no longer supported
- Adobe Reader or other PDF reader software for certificate viewing/printing